Please provide your email address to receive an email when new articles are posted on . Patients with chronic kidney disease and their care partners report a considerable burden, especially when the ...

Agios Pharmaceuticals has announced a major regulatory milestone with the U.S. Food and Drug Administration approving ...

Agios Pharmaceuticals (AGIO) “announced that the U.S. Food and Drug Administration has approved AQVESME, or mitapivat, an oral pyruvate kinase ...

“Depending on the patient’s situation, there are pluses and minuses for treatments like medications or growth factors, and the patient guidelines aim to present balanced information on these options ...

The use of aspirin for primary prevention has fallen out of favor following changes to clinical guidelines prompted by results from multiple trials: now, an analysis from one of those studies ...

In a statement, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) said that the FDA officially approved Aqvesme to treat anemia in ...

Anemia is a common finding in patients with diabetes due to the high burden of chronic kidney disease in this population. Anemia is more prevalent and is found earlier in patients with diabetes than ...

Anemia occurs frequently in patients with cancer, with estimates reaching as high as 90% in those with solid tumors. The red blood cell disorder, which may develop because of tumor-related features or ...

For years, national medical guidelines have defined anemia differently for patients who are Black. Notably, over the years researchers and clinicians have observed significantly lower levels of iron ...

Serum ferritin of 100 ng/mL or less is a reasonable indicator for prompt colonoscopy among men with unexplained anemia. Older patients with unexplained anemia are often referred for colonoscopy as a ...